High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis

Gut

Volumn 44, Issue 6, 1999, Pages 867-873

  Sobajima, J ^a   Ozaki, S ^a   Uesugi, H ^a   Osakada, F ^b   Inoue, M ^a   Fukuda, Y ^a   Shirakawa, H ^c   Yoshida, M ^c   Rokuhara, A ^d   Imai, H ^d   Kiyosawa, K ^d   Nakao, K ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANEKA CORPORATION   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmune; Chromosomal proteins; Hepatitis; High mobility group 1 and 2; Perinuclear anti neutrophil cytoplasmic antibodies

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CATHEPSIN G; HIGH MOBILITY GROUP PROTEIN; LACTOFERRIN; MITOCHONDRION ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONHISTONE PROTEIN; SMOOTH MUSCLE ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0032981786     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.6.867     Document Type: Article

References (37)

1. Lüdemann J, Utecht B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990;171:357-62.
2. Cohen Tervaert JW, van der Woude FJ, Fauci AS, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989;149:2461-5.
3. Nölle B, Specks U, Lüdemann I, et al. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111:28-40.
4. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
5. Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
6. Duerr RH, Targan SR, Landers CJ, et al. Antineutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590-6.
7. Seibold F, Weber P, Klein R, et al. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992;33:657-62.
8. Cambridge G, Rampton DS, Stevens TRJ, et al. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992;33:668-74.
9. Klein R, Eisenburg J, Weber P, et al. Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology 1991;14:1147-52.
10. Mulder AHL, Horst G, Haagsma EB, et al. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoinumme liver diseases. Hepatology 1993;17:411-17.
11. Vidrich A, Lee J, James E, et al. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J Clin Immunol 1995;15:293-9.
12. Hardarson S, Labrecque DR, Mitros FA, et al. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: high prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis. Clin Microbiol Immunol 1993;99:277-81.
13. Targan SR, Landers C, Vidrich A, et al. High-titre antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995;108:1159-66.
14. Orth T, Gerken G, Kellner R, et al. Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1. J Hepatol 1997;26:37-47.
15. Orth T, Keller R, Diekmann SO, et al. Identification and characterization of new ANCA antigens in patients with primary sclerosing cholangitis: catalase and alpha-enolase. Clin Exp Immunol 1998;112(suppl 1):45.
16. Sobajima J, Ozaki S, Okazaki T, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anticathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 1996;105:120-5.
17. Sobajima J, Ozaki S, Osakada F, et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol 1997;107:135-40.
18. Sobajima J, Ozaki S, Uesugi H, et al. Prevalence and characterization of p-ANCA directed against HMG1 and HMG2 in ulcerative colitis. Clin Exp Immunol 1998;111:402-7.
19. Uesugi H, Ozaki S, Sobajima J, et al. Prevalence and characterization of novel p-ANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J Rheumatol 1998; 25:703-9.
20. Bustin M, Lehn DA, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1990;1049:231-43.
21. Einck L, Bustin M. The intracellular distribution and function of the high mobility group chromosomal proteins. Exp Cell Res 1985;156:295-310.
22. Bustin M, Neihart NK. Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell 1979;16:181-9.
23. Uesugi H, Ozaki S, Sobajima J, et al. High mobility group non-histone chromosomal proteins HMG1 and HMG2: Are they p-ANCA target antigens? Clin Exp Immunol 1998; 112(suppl 1):52.
24. Majumdar A, Brown D, Kerby S, et al. Sequence of human HMG2 cDNA. Nucleic Acids Res 1991;19:6643.
25. Wen L, Huang JK, Johnson BH, et al. A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res 1989;17:1197-214.
26. Shirakawa H, Yoshida M. Structure of a gene ending for human HMG2 protein. J Biol Chem 1992;267:6641-5.
27. Shirakawa H, Tsuda K, Yoshida M. Primary structure of non-histone chromosomal protein HMG2 revealed by the nucleotide sequence. Biochemistry 1990;29:4119-23.
28. Halbwachs-Mecarelli L, Nusbaum P, Noël LH, et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992;90:79-84.
29. Peen E, Almer S, Bodemar G, et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 1993;34:56-62.
30. Ohta Y. Report of the research subgroup of autoimmune hepatitis/primary biliary cirrhosis. Gastroenterol Jpn 1993; 28(suppl 4):128-33.
31. Johnson PJ, Macfarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology 1993;18:998-1005.
32. Yoshida M, Shimura K. Unwinding of DNA by nonhistone chromosomal protein HMG(1+2) from pig thymus as determined with endonuclease. J Biochem (Tokyo) 1984;95:117-24.
33. Wiik A. Delineation of a standard procedure for indirect immunofluorencence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989;97:12-13.
34. Lesavre P, Nusbaum P, Halbwachs-Mecarelli. Methods of detection of anticathepsin G autoantibodies in human. In: Gross WL, ed. ANCA-associated vasculitides: immunological and clinical aspects. New York: Plenum Press, 1993:257-61.
35. Merenmies J, Pihlaskari R, Laitinen J, et al. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth: amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 1991;266:16722-9.
36. Parkkinen J, Raulo E, Merenmies J, et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides: enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem 1993;268:19726-38.
37. Melloni E, Sparatore B, Patrone M, et al. Extracellular release of the 'differentiation enhancing factor' a HMG1 protein type, is an early step in murine erythroleukemia cell differentiation. FEBS Lett 1995;368:466-70.